113 related articles for article (PubMed ID: 1451816)
1. Peroperative anticoagulation with antithrombin or heparin in infrainguinal bypass surgery.
Nydahl S; Swedenborg J; Egberg N
Eur J Vasc Surg; 1992 Nov; 6(6):610-5. PubMed ID: 1451816
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
Dörffler-Melly J; Büller HR; Koopman MM; Prins MH
Cochrane Database Syst Rev; 2003; (4):CD000536. PubMed ID: 14583924
[TBL] [Abstract][Full Text] [Related]
3. Low molecular mass heparin instead of unfractionated heparin during infrainguinal bypass surgery.
Swedenborg J; Nydahl S; Egberg N
Eur J Vasc Endovasc Surg; 1996 Jan; 11(1):59-64. PubMed ID: 8564488
[TBL] [Abstract][Full Text] [Related]
4. Coagulation responses to heparin in the ischemic limb: assessment of thrombin and platelet activation during vascular surgery.
Sobel M; Gervin CA; Qureshi DG; Greenfield LJ
Circulation; 1987 Sep; 76(3 Pt 2):III8-13. PubMed ID: 2957118
[TBL] [Abstract][Full Text] [Related]
5. [Perioperative changes in blood coagulation in aortofemoral bifurcation bypass].
Fraunhofer S; Fraunhofer J; von Sommoggy S; Maurer PC
Vasa Suppl; 1992; 35():118-9. PubMed ID: 1282736
[No Abstract] [Full Text] [Related]
6. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
[TBL] [Abstract][Full Text] [Related]
7. Dose response of intravenous heparin on markers of thrombosis during primary total hip replacement.
Sharrock NE; Go G; Sculco TP; Salvati EA; Westrich GH; Harpel PC
Anesthesiology; 1999 Apr; 90(4):981-7. PubMed ID: 10201667
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
[TBL] [Abstract][Full Text] [Related]
9. Hemorrhage and thrombosis as early complications of femoropopliteal bypass grafts: causes, treatment, and prognostic implications.
Craver JM; Ottinger LW; Darling RC; Austen WG; Linton RR
Surgery; 1973 Dec; 74(6):839-45. PubMed ID: 4749628
[No Abstract] [Full Text] [Related]
10. Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis.
Wilhelmsson S; Asaba H; Gunnarsson B; Kudryk B; Robinson D; Bergström J
Clin Nephrol; 1981 May; 15(5):252-8. PubMed ID: 7249422
[TBL] [Abstract][Full Text] [Related]
11. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
Weitz JI; Leslie B; Hudoba M
Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
[TBL] [Abstract][Full Text] [Related]
12. [20 years orthograde venous bypass for infrainguinal arterial reconstruction].
Böhmig HJ; Zeidler G; Schwierz T; Loy E
Chirurg; 1995 Feb; 66(2):120-6. PubMed ID: 7712854
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
14. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
Mombelli G; Marchetti O; Haeberli A; Straub PW
Am Heart J; 1998 Dec; 136(6):1106-13. PubMed ID: 9842027
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats.
Schoots IG; Levi M; van Vliet AK; Maas AM; Roossink EH; van Gulik TM
Crit Care Med; 2004 Jun; 32(6):1375-83. PubMed ID: 15187522
[TBL] [Abstract][Full Text] [Related]
16. Fibrinopeptide A (FPA) levels in atrial fibrillation and the effects of heparin administration.
Uno M; Tsuji H; Sawada S; Toyoda T; Nakagawa M
Jpn Circ J; 1988 Jan; 52(1):9-12. PubMed ID: 3361696
[TBL] [Abstract][Full Text] [Related]
17. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques.
Owings JT; Pollock ME; Gosselin RC; Ireland K; Jahr JS; Larkin EC
Arch Surg; 2000 Sep; 135(9):1042-7. PubMed ID: 10982508
[TBL] [Abstract][Full Text] [Related]
19. Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction.
Mombelli G; Im Hof V; Haeberli A; Straub PW
Circulation; 1984 Apr; 69(4):684-9. PubMed ID: 6697455
[TBL] [Abstract][Full Text] [Related]
20. Nafamostat mesilate administration during cardiopulmonary bypass decreases postoperative bleeding after cardiac surgery.
Sato T; Tanaka K; Kondo C; Morimoto T; Yada I; Yuasa H; Kusagawa M; Deguchi K
ASAIO Trans; 1991; 37(3):M194-5. PubMed ID: 1751106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
